ReviewRheumatology international2023

Anti-programmed death-1 inhibitor nivolumab-induced immune-related adverse events: hepatitis, renal insufficiency, myositis, vitiligo, and hypothyroidism: a case-based review.

Tatjana Zekić et al.PubMed ↗Publisher ↗

No numbers read from the abstract.